🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to users administering products of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the service has taken down violative content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of weight loss, positive reviews and step-by-step guides for mixing or injecting at home.

Within moments of entering one community, a seller shared WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Information and Pricing

Within these groups, posts display black plastic parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they can’t verify. Even if the research behind this drug is sound, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has already encountered individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially serious health risks”.